DHR - Danaher Corporation Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

DHR

DANAHER CORPORATION

NYSE

$206.93

▼ DOWN 3.10% (-6.63)

KEY STATISTICS

Market Cap$145.42 B

52w High$242.80

52w Low$160.93

Dividend Yield0.74%

FrequencyQuarterly

P/E25.93

Volume3.14M

Shares Out.702.99M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Rainer Blair

COMPENSATION 2026

Salary$1,300,000

Stock Awards$8,068,474

Incentive Plan Pay$3,541,200

All Other Comp.$484,191

Total$20,903,282

ABOUT

SECTOR

Healthcare

WENT PUBLIC

December 29, 1978

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

59,000

PRICE TARGET

Target High$249.00

Target Low$195.00

Target Median$225.00

Target Consensus$221.58

UPCOMING EARNINGS

DateOct 20, 2026

DayTuesday

Rev. Est.$6.54B

OCT

TUE

SPLIT RECORD

DATE	TYPE	RATIO
2023-10-02	Forward	141:125
2016-07-05	Forward	1319:1000
2010-06-14	Forward	2:1
2004-05-21	Forward	2:1
1998-06-01	Forward	2:1
1995-01-23	Forward	2:1
1987-09-09	Forward	2:1

PRICE

$206.93 ▼ DOWN 3.10% (−$6.63)

OVERLAYS

About Danaher Corporation

https://www.danaher.com ↗

Danaher Corporation designs and markets global professional, medical, industrial, and environmental products across three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT DANAHER CORPORATION IS KNOWN FOR

ZenoTOF 8600 system

In June 2025, SCIEX launched a cutting-edge mass spectrometer delivering rapid, high-resolution, and highly sensitive analysis of complex biological samples for proteomics, metabolomics, and genomics applications.

COMPETITORS

COMPETITOR

Revenue by Products

Icon	PRODUCT	Q3-2025	Q4-2025	Q1-2026	Q2-2026
	Revenue from Contract with Customer Measurement Recurring	$5.02B	$5.32B ▲	$5.03B ▼	$5.2B ▲
	Revenue from Contract with Customer Measurement Nonrecurring	$1.04B	$1.51B ▲	$920M ▼	$1.06B ▲